SEC Form 4/A · accession 0001209191-18-057372
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John Maraganore
Director
Period of report
Sep 12, 2018
Accepted (ET)
Nov 6, 2018 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Sep 12, 2018 | S$0 | 0 | — | D | 36,209 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 13, 2018, the reporting person filed a Form 4 reporting the sale of 14,162 shares of common stock. The previously reported transaction was subsequently broken and unwound by the broker and, therefore, did not in fact occur for the reporting person's account. As of September 12, 2018, the reporting person beneficially owned 36,209 shares of common stock of Agios Pharmaceuticals, Inc.